A Double-Blind, Randomized Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo ® as Monotherapy in Subjects With Advanced Melanoma of the Skin

Conditions: Advanced Melanoma Interventions: Drug: BCD-263; Drug: Opdivo Sponsors: Biocad Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials